Letermovir Effectively Prevents Cytomegalovirus Disease In Kidney Transplant Recipients With Fewer Side Effects Than Valganciclovir, Study Finds

October 27, 2022

Healio (10/26, Feller) reports “letermovir effectively prevented cytomegalovirus disease among kidney transplant” recipients “with fewer side effects than valganciclovir, according to a study.” In addition, “more patients completed the letermovir treatmen...